HCC Biomarkers
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is the third leading cause of cancer-related death in the world. Major risk factors for liver cancer include infection with HBV and/or HCV, or alcoholic liver disease.
Please find here all information about our HCC products.
µTASWako™ AFP-L3 Test
µTASWako™ AFP-L3 Test is an in vitro diagnostic blood test for the risk assessment of developing Hepatocellular Carcinoma (HCC). AFP-L3 is an...
µTASWako™ DCP Test
µTASWako™ DCP Test is an in vitro diagnostic blood test for the risk assessment of developing Hepatocellular Carcinoma (HCC). DCP...
µTASWako™ i30
µTASWako™ i30 (Micro Total Analysis System) is the worldwide unique system for the automated measurement of the biomarkers AFP-L3 and DCP. Both,...
Viewed